PARP inhibition protects mitochondria and reduces ROS production via PARP-1-ATF4-MKP-1-MAPK retrograde pathway

Eniko Hocsak, Viktor Szabo, Nikoletta Kalman, Csenge Antus, Anna Cseh, Katalin Sumegi, Krisztian Eros, Z. Hegedűs, F. Gallyas, B. Sümegi, B. Rácz

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

Oxidative stress induces DNA breaks and PARP-1 activation which initiates mitochondrial reactive oxygen species (ROS) production and cell death through pathways not yet identified. Here, we show the mechanism by which PARP-1 influences these processes via PARylation of activating transcription factor-4 (ATF4) responsible for MAP kinase phosphatase-1 (MKP-1) expression and thereby regulates MAP kinases. PARP inhibitor, or silencing, of PARP induced MKP-1 expression by ATF4-dependent way, and inactivated JNK and p38 MAP kinases. Additionally, it induced ATF4 expression and binding to cAMP-response element (CRE) leading to MKP-1 expression and the inactivation of MAP kinases. In contrast, PARP-1 activation induced the PARylation of ATF4 and reduced its binding to CRE sequence in vitro. CHIP-qPCR analysis showed that PARP inhibitor increased the ATF4 occupancy at the initiation site of MKP-1. In oxidative stress, PARP inhibition reduced ROS-induced cell death, suppressed mitochondrial ROS production and protected mitochondrial membrane potential on an ATF4 and MKP-1 dependent way. Basically identical results were obtained in WRL-68, A-549 and T24/83 human cell lines indicating that the aforementioned mechanism can be universal. Here, we provide the first description of PARP-1-ATF4-MKP-1-JNK/p38 MAPK retrograde pathway, which is responsible for the regulation of mitochondrial integrity, ROS production and cell death in oxidative stress, and may represent a new mechanism of PARP in cancer therapy since cancer stem cells development is JNK-dependent.

Original languageEnglish
Pages (from-to)770-784
Number of pages15
JournalFree Radical Biology and Medicine
Volume108
DOIs
Publication statusPublished - Jul 1 2017

Fingerprint

Activating Transcription Factor 4
Dual Specificity Phosphatase 1
Mitochondria
Reactive Oxygen Species
Phosphotransferases
Oxidative stress
Cell death
Response Elements
p38 Mitogen-Activated Protein Kinases
Oxidative Stress
Cell Death
Chemical activation
DNA Breaks
Neoplastic Stem Cells
phosphatase-1 kinase
Stem cells
Mitochondrial Membrane Potential
Cells
Membranes

Keywords

  • ATF4
  • Cancer
  • CREB
  • CREB2
  • Dusp1
  • JNK
  • MKP-1
  • Oxidative stress
  • P38 MAPK
  • PARP-1 inhibition
  • ROS
  • Stem cells

ASJC Scopus subject areas

  • Biochemistry
  • Physiology (medical)

Cite this

PARP inhibition protects mitochondria and reduces ROS production via PARP-1-ATF4-MKP-1-MAPK retrograde pathway. / Hocsak, Eniko; Szabo, Viktor; Kalman, Nikoletta; Antus, Csenge; Cseh, Anna; Sumegi, Katalin; Eros, Krisztian; Hegedűs, Z.; Gallyas, F.; Sümegi, B.; Rácz, B.

In: Free Radical Biology and Medicine, Vol. 108, 01.07.2017, p. 770-784.

Research output: Contribution to journalArticle

Hocsak, Eniko ; Szabo, Viktor ; Kalman, Nikoletta ; Antus, Csenge ; Cseh, Anna ; Sumegi, Katalin ; Eros, Krisztian ; Hegedűs, Z. ; Gallyas, F. ; Sümegi, B. ; Rácz, B. / PARP inhibition protects mitochondria and reduces ROS production via PARP-1-ATF4-MKP-1-MAPK retrograde pathway. In: Free Radical Biology and Medicine. 2017 ; Vol. 108. pp. 770-784.
@article{a84c9470f4ec4925ac9c826281e41486,
title = "PARP inhibition protects mitochondria and reduces ROS production via PARP-1-ATF4-MKP-1-MAPK retrograde pathway",
abstract = "Oxidative stress induces DNA breaks and PARP-1 activation which initiates mitochondrial reactive oxygen species (ROS) production and cell death through pathways not yet identified. Here, we show the mechanism by which PARP-1 influences these processes via PARylation of activating transcription factor-4 (ATF4) responsible for MAP kinase phosphatase-1 (MKP-1) expression and thereby regulates MAP kinases. PARP inhibitor, or silencing, of PARP induced MKP-1 expression by ATF4-dependent way, and inactivated JNK and p38 MAP kinases. Additionally, it induced ATF4 expression and binding to cAMP-response element (CRE) leading to MKP-1 expression and the inactivation of MAP kinases. In contrast, PARP-1 activation induced the PARylation of ATF4 and reduced its binding to CRE sequence in vitro. CHIP-qPCR analysis showed that PARP inhibitor increased the ATF4 occupancy at the initiation site of MKP-1. In oxidative stress, PARP inhibition reduced ROS-induced cell death, suppressed mitochondrial ROS production and protected mitochondrial membrane potential on an ATF4 and MKP-1 dependent way. Basically identical results were obtained in WRL-68, A-549 and T24/83 human cell lines indicating that the aforementioned mechanism can be universal. Here, we provide the first description of PARP-1-ATF4-MKP-1-JNK/p38 MAPK retrograde pathway, which is responsible for the regulation of mitochondrial integrity, ROS production and cell death in oxidative stress, and may represent a new mechanism of PARP in cancer therapy since cancer stem cells development is JNK-dependent.",
keywords = "ATF4, Cancer, CREB, CREB2, Dusp1, JNK, MKP-1, Oxidative stress, P38 MAPK, PARP-1 inhibition, ROS, Stem cells",
author = "Eniko Hocsak and Viktor Szabo and Nikoletta Kalman and Csenge Antus and Anna Cseh and Katalin Sumegi and Krisztian Eros and Z. Hegedűs and F. Gallyas and B. S{\"u}megi and B. R{\'a}cz",
year = "2017",
month = "7",
day = "1",
doi = "10.1016/j.freeradbiomed.2017.04.018",
language = "English",
volume = "108",
pages = "770--784",
journal = "Free Radical Biology and Medicine",
issn = "0891-5849",
publisher = "Elsevier Inc.",

}

TY - JOUR

T1 - PARP inhibition protects mitochondria and reduces ROS production via PARP-1-ATF4-MKP-1-MAPK retrograde pathway

AU - Hocsak, Eniko

AU - Szabo, Viktor

AU - Kalman, Nikoletta

AU - Antus, Csenge

AU - Cseh, Anna

AU - Sumegi, Katalin

AU - Eros, Krisztian

AU - Hegedűs, Z.

AU - Gallyas, F.

AU - Sümegi, B.

AU - Rácz, B.

PY - 2017/7/1

Y1 - 2017/7/1

N2 - Oxidative stress induces DNA breaks and PARP-1 activation which initiates mitochondrial reactive oxygen species (ROS) production and cell death through pathways not yet identified. Here, we show the mechanism by which PARP-1 influences these processes via PARylation of activating transcription factor-4 (ATF4) responsible for MAP kinase phosphatase-1 (MKP-1) expression and thereby regulates MAP kinases. PARP inhibitor, or silencing, of PARP induced MKP-1 expression by ATF4-dependent way, and inactivated JNK and p38 MAP kinases. Additionally, it induced ATF4 expression and binding to cAMP-response element (CRE) leading to MKP-1 expression and the inactivation of MAP kinases. In contrast, PARP-1 activation induced the PARylation of ATF4 and reduced its binding to CRE sequence in vitro. CHIP-qPCR analysis showed that PARP inhibitor increased the ATF4 occupancy at the initiation site of MKP-1. In oxidative stress, PARP inhibition reduced ROS-induced cell death, suppressed mitochondrial ROS production and protected mitochondrial membrane potential on an ATF4 and MKP-1 dependent way. Basically identical results were obtained in WRL-68, A-549 and T24/83 human cell lines indicating that the aforementioned mechanism can be universal. Here, we provide the first description of PARP-1-ATF4-MKP-1-JNK/p38 MAPK retrograde pathway, which is responsible for the regulation of mitochondrial integrity, ROS production and cell death in oxidative stress, and may represent a new mechanism of PARP in cancer therapy since cancer stem cells development is JNK-dependent.

AB - Oxidative stress induces DNA breaks and PARP-1 activation which initiates mitochondrial reactive oxygen species (ROS) production and cell death through pathways not yet identified. Here, we show the mechanism by which PARP-1 influences these processes via PARylation of activating transcription factor-4 (ATF4) responsible for MAP kinase phosphatase-1 (MKP-1) expression and thereby regulates MAP kinases. PARP inhibitor, or silencing, of PARP induced MKP-1 expression by ATF4-dependent way, and inactivated JNK and p38 MAP kinases. Additionally, it induced ATF4 expression and binding to cAMP-response element (CRE) leading to MKP-1 expression and the inactivation of MAP kinases. In contrast, PARP-1 activation induced the PARylation of ATF4 and reduced its binding to CRE sequence in vitro. CHIP-qPCR analysis showed that PARP inhibitor increased the ATF4 occupancy at the initiation site of MKP-1. In oxidative stress, PARP inhibition reduced ROS-induced cell death, suppressed mitochondrial ROS production and protected mitochondrial membrane potential on an ATF4 and MKP-1 dependent way. Basically identical results were obtained in WRL-68, A-549 and T24/83 human cell lines indicating that the aforementioned mechanism can be universal. Here, we provide the first description of PARP-1-ATF4-MKP-1-JNK/p38 MAPK retrograde pathway, which is responsible for the regulation of mitochondrial integrity, ROS production and cell death in oxidative stress, and may represent a new mechanism of PARP in cancer therapy since cancer stem cells development is JNK-dependent.

KW - ATF4

KW - Cancer

KW - CREB

KW - CREB2

KW - Dusp1

KW - JNK

KW - MKP-1

KW - Oxidative stress

KW - P38 MAPK

KW - PARP-1 inhibition

KW - ROS

KW - Stem cells

UR - http://www.scopus.com/inward/record.url?scp=85018737106&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85018737106&partnerID=8YFLogxK

U2 - 10.1016/j.freeradbiomed.2017.04.018

DO - 10.1016/j.freeradbiomed.2017.04.018

M3 - Article

C2 - 28457938

AN - SCOPUS:85018737106

VL - 108

SP - 770

EP - 784

JO - Free Radical Biology and Medicine

JF - Free Radical Biology and Medicine

SN - 0891-5849

ER -